What changed today in Metabolic: 3 trial updates, 1 new study
Every new official record on the Metabolic & Weight-Loss Intelligence desk since this morning, each linked to its primary source.
The signal
NPHLA tracked 4 new official records on this desk today: 3 trial updates, 1 new study.
Why this matters
GLP-1 and obesity-medicine developments can change access, supply, clinical evidence and patient conversations for clinics, pharmacies and prescribers.
What changed
- New trial registered: Effects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity[1]
- New trial registered: Study to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes[2]
- New research in Diabetes, obesity & metabolism: “Testosterone Added to Incretin Therapy in Men With Overweight or Obesity: A Systematic Review of Body Composition Evidence and Gaps”.[3]
- Trial status changed to “Active, not recruiting”: STAY SEC PsO (A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or…)[4]
- Also reported by Pharmacy Times: “Updates on Glucagon-Like Peptide-1 Receptor Agonists for Diabetes and Obesity”.[5]
- Also reported by Pharmacy Times: “Survodutide for Obesity and CV Risk: Liver, Lipids, and Beyond”.[6]
- Also reported by Pharmacy Times: “Semaglutide Cuts BMI in Young Children With Obesity in STEP Young”.[7]
Who this affects
- Weight-management clinics
- Med spas
- Pharmacists
- Prescribers
- Medical directors
- Practice owners & operators
What to watch next
No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.
NPHLA takeaway
These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.
Source file
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.
Update timeline
- First published.
- Added 1 new official record.

